Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q2 2021 call → NOWe need answer YES/NO based on transcript. Need determine if management describes company currently living through defined waiting period paying out of own pocket, with cost currently landing, wait is main current work, far side specific near-dated event already visible and work in motion. Look at transcript. Management discusses Clifton lab: "We're on scheduled to complete the full transition to our new flagship laboratory in Clifton, New Jersey next month. This highly automated facility has consolidated testing previously performed in Teterboro, Baltimore and Philadelphia." Also in Q&A: "Clifton lab went live in January and Steve, I think you said the consolidation from it will wrap up here next month... Just curious if there are any data points to share so far on how the consolidation is going, and how we should think about the impact to margins as volumes consolidated into Clifton?" Steve: "We're pleased with what we're able to do. It's pretty remarkable that we built this facility in the middle of the pandemic and for all intents and purposes that are on track and it's up and running. And we bring in this facility to do that consolidation, we have to continue our program around organizational processes and harmonization around systems to get them all in the same platform within the new facility. So we're on the final strokes of that implementation, we feel good about it. And then in that facility, we have implemented a lot of the new systems... We are getting some pretty good gains for them and more to come. We’ll put in place new front end automation... So we are pleased with the progress made so far and we're looking forward to more productivity from that going forward as we continue to burn in systems and work out some of the early details and those improvements are already part of the 3% productivity gains that we have in our operational excellence program and that are already included in our outlook that we provided at Investor Day." Does this describe currently paying for something not yet earning? The lab is already up and running, consolidation ongoing, but they are getting gains already. They mention "we have to continue our program... final strokes" but not explicitly carrying cost with no benefit. They say "we are getting some pretty good gains" already.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.